be_ixf;ym_202411 d_22; ct_50
NASDAQ:IOVA charts & data provided by TradingView

Latest Insights on IOVA

I don’t want to be the bad guy, but rising gas prices and promises of trade war progress do not a bull market make. Aurora Gets Stoned, Trade War Optimism Is Smokin’
by Joseph Hargett November 15, 2019 Great Stuff
Friday Four Play: The “Fighting for Optimism” Edition How bad does Wall Street want a U.S.-China trade deal? So bad that the markets are rallying (once again) on reports that a trade deal is close. Last night, White House economic advisor Lawrence Kudlow said that the two sides were making “very good progress” on a […]
Great Stuff 9-19-2019 Roku Investors out of Touch; Microsoft’s Handing out Cash
by Joseph Hargett September 19, 2019 Great Stuff
Out of Touch on Streaming Shake it up is all that Wall Street knows. Using companies up as they go. But those companies really matter to me. Take a look around. Investors are out of touch with the streaming-device market, but they’re not out of time. (OK, I’ll stop paraphrasing Hall & Oates lyrics now.) […]
Great Stuff 7-2-2019 Long Live the Trade War – New Tariffs Fuel Market Uncertainty
by Joseph Hargett July 2, 2019 Great Stuff
Did you enjoy yesterday’s break from the trade war? It was fun for a day, wasn’t it? Semiconductors rallied. Oil stocks gained ground. The market hit all-time highs. For a brief moment, we were able to shrug off global uncertainties and bask in the remnants of the bull market. Today, that illusion of certainty is […]
I’ve experienced the absurdity of American health care enough to know that the possibility of a “Medicare for All” program is real. That calls for some seriously strategic investing. Get Ready to Trade Medicare for All’s Volatility
by Ted Bauman April 24, 2019 Government & Politics, U.S. Economy, Winning Investor Daily
I’ve experienced the absurdity of American health care enough to know that the possibility of a “Medicare for All” program is real. That calls for some seriously strategic investing.
Biopharmaceutical companies attract millions of investors. All it takes is one blockbuster drug, and the shares are off to the races. Amarin Stock Soared 570% And Is Maintaining Momentum
by Joseph Hargett October 19, 2018 Investment Opportunities
Biopharmaceutical companies attract millions of investors. All it takes is one blockbuster drug, and the shares are off to the races.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

Share This